% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Badenes:144531,
author = {Badenes, Sara M and Fernandes, Tiago G and Miranda,
Cláudia C and Pusch-Klein, Annette and Haupt, Simone and
Rodrigues, Carlos AV and Diogo, Maria Margarida and
Brüstle, Oliver and Cabral, Joaquim MS},
title = {{L}ong-term expansion of human induced pluripotent stem
cells in a microcarrier-based dynamic system},
journal = {Journal of chemical technology $\&$ biotechnology},
volume = {92},
number = {3},
issn = {0268-2575},
address = {Chichester},
publisher = {Wiley},
reportid = {DZNE-2020-00068},
pages = {492-503},
year = {2017},
abstract = {BACKGROUND: Human induced pluripotent stem (hiPS) cells
provide a fascinating tool for exploring disease mechanisms,
compound screening in pharmaceutical drug development, and
might also represent a renewable source of cells for
regenerative medicine applications. This requires increased
cell quantities, generated under Good Manufacturing
Practice-compatible conditions in a scalable system.RESULTS:
A microcarrier-based suspension culture was explored for
scaling-up hiPS cell expansion in serum-free medium using
synthetic peptide-acrylate surface microcarriers, developed
for long-term support of hiPS cell self-renewal. After a 7
day-culture in a spinner flask, cells maintained their
typical morphology, pluripotency-associated marker
expression and their differentiation capability. Envisaging
improvement of the scalability of the culture, long-term
expansion on the microcarriers was attained using confluent
microcarriers as the inoculum of successive spinner flask
cultures. Importantly, bead-to-bead cell transfer allowed
four consecutive sub-culture procedures and a cumulative
241-fold expansion was achieved within 15 days, leading to a
total viable cell number of 3.3 × 108 cells.CONCLUSION:
This work is expected to enable the scale-up of hiPS cell
culture under defined conditions and potentially leading to
the use of pluripotent stem cell derivatives in cell
replacement therapies.},
cin = {Cell Programming Unit},
ddc = {620},
cid = {I:(DE-2719)1013013},
pnm = {344 - Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)16},
doi = {10.1002/jctb.5074},
url = {https://pub.dzne.de/record/144531},
}